Renovion is a clinical stage pharmaceutical company with a nebulized therapy that restores mucus clearance and reduces inflammation in the lungs. We are focused on developing ARINA-1 for orphan chronic inflammatory lung diseases.  

With over 25 patient years of experience, ARINA-1 is poised to start clinical studies in cystic fibrosis, primary ciliary dyskinesia and alpha-1 anti-trypsin deficiency patients.

© 2019 by Renovion, Inc. Proudly created with